G-Irascens Gold

Natural health product licensed in Canada

Other names: G-statera
Licence holder: Royal Academy of Nutrition Science
NPN or DIN-HM: 80095356
Status: Active licence
Licence date: 15 November 2019
Revision date: 27 March 2022
Form: Capsule, dur
Route of administration: Orale
Application type: Non traditionnelle

If this product were sold in France

Dose déclarée au-delà d'une limite
Chrome: up to 60 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
Glycine max Source : Seed Coat Extract : Matériel brut sec Extraction ratio : 30:1 Dry plant equivalent : 6,000 mg Potency : 25 % Cyanidin 3-O-glucoside	200 mg	Not calculated
Vaccinium macrocarpon Source : Fruit Extract : Matériel brut frais Extraction ratio : 90:1 Dry plant equivalent : 2,700 mg	30 mg	Not calculated
Chrome Source : Nicotinate de chrome (III)	30 mcg	60 µg
Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque	300 mg	Not calculated

Non-medicinal ingredients

Cellulose microcristalline, Stéarate de magnésium, Hypromellose

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	minimum: 19 years	1 Capsule	2 Tous les jours

Uses authorised in Canada

(1) Source of/Provides antioxidants. (2) Provides support for healthy glucose metabolism. (3) Helps to maintain normal blood glucose levels. (4) Helps to maintain the body's ability to metabolize nutrients. (5) Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. (6) Helps to promote healthy glucose metabolism.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80095356

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated 27 March 2022 (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging